Product
XW003
Aliases
ecnoglutide, XW003 injection
2 clinical trials
2 indications
Indication
Healthy Control ParticipantsIndication
ObesityClinical trial
A Single-Center, Open-Label Study to Evaluate the Effect of XW003 Injection on the Pharmacokinetics of Metformin, Warfarin, Rosuvastatin or Digoxin in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2024-01-08
Clinical trial
A Phase 2, Open-label, Randomised, Dose-Finding Study of XW003, Once-Weekly Human Glucagon-Like Peptide 1 Analogue, Compared With Once-Daily Liraglutide 3 mg in Adult Participants With ObesityStatus: Completed, Estimated PCD: 2022-11-16